Baixar PDF
Artigo anterior
Voltar à página
Artigo seguinte
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
Epidemiology and risk factors for the development of infectious complications in newly diagnosed multiple myeloma: a multicenter prospective cohort study in Uruguay
Eloísa Riva; David Garrido; Fiorella Villano; Virginia Bove;
Hematol Transfus Cell Ther. 2024;46:434-42
Results of the daratumumab monotherapy early access treatment protocol in patients from Brazil with relapsed or refractory multiple myeloma
Edvan de Queiroz Crusoé; Flávia Cristina Fernandes Pimenta; Angelo Maiolino; Nelson Siqueira de Castro; Huiling Pei; Damila Trufelli; Mariana Fernandez; Luciana Barreto Herriot;
Hematol Transfus Cell Ther. 2021;43:417-23
CT-SEGMENTED BONE SUV IN MULTIPLE MYELOMA: A COMPARATIVE STUDY OF ¹¿F-FDG AND ¿¿GA-PSMA PET/CT
Alexandre Mercuri Barbosa; Maria Emília Seren Takahashi; Stephan Pinheiro Macedo Souza; Edna Marina Souza; Sérgio Querino Brunetto; Cármino Antonio de Souza; Irene Gyongyver Heidemarie Lorand-Metze; Celso Darío Ramos;
Hematol Transfus Cell Ther. 2025;47 Supl 1: